Search

everythinglearnresearchcommunity

for

Search:↓

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Certain cells outside the hair follicle's bulge area can quickly regenerate damaged hair follicles, potentially helping to reduce hair loss from cancer treatments.

Scalp cooling does not stop hair loss from radiotherapy.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Hair mass index is a precise way to measure hair loss in chemotherapy patients.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Hair loss in women is complex to diagnose and treat, and hair restoration should be done by experts. Using minoxidil before surgery can help manage post-surgery hair shock loss. The Follicular Unit Transplantation method is recommended for women due to its speed, no need for shaving, and better graft quality. Strategies like L, T, and reverse L patterns can help restore central hair density, and regenerative methods can improve graft survival in hair transplants.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

A critically ill boy experienced hair loss likely due to the stress of his medical treatments, but his hair regrew completely in 1.5 months.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Some medications can cause hair loss, and it's important to track when the hair loss starts after taking a new medication.

A healthy woman got a chest abscess from a fungal infection after gallbladder surgery, which was treated but caused temporary hair loss due to the antifungal medication.

Accurate diagnosis and tailored treatments are crucial for managing hair loss in humans and animals.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Chemotherapy causes hair loss in cancer patients by affecting both growing and resting hair.

An imbalanced gut and lack of biotin can cause hair loss in mice.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.